List of Tables
Table 1. Global Drug based on CAR T-Cell Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CD19-targeted
Table 3. Key Players of BCMA-targeted
Table 4. Global Drug based on CAR T-Cell Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Drug based on CAR T-Cell Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Drug based on CAR T-Cell Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Drug based on CAR T-Cell Market Share by Region (2020-2025)
Table 8. Global Drug based on CAR T-Cell Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Drug based on CAR T-Cell Market Share by Region (2026-2031)
Table 10. Drug based on CAR T-Cell Market Trends
Table 11. Drug based on CAR T-Cell Market Drivers
Table 12. Drug based on CAR T-Cell Market Challenges
Table 13. Drug based on CAR T-Cell Market Restraints
Table 14. Global Drug based on CAR T-Cell Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Drug based on CAR T-Cell Market Share by Players (2020-2025)
Table 16. Global Top Drug based on CAR T-Cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug based on CAR T-Cell as of 2024)
Table 17. Ranking of Global Top Drug based on CAR T-Cell Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Drug based on CAR T-Cell Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Drug based on CAR T-Cell, Headquarters and Area Served
Table 20. Global Key Players of Drug based on CAR T-Cell, Product and Application
Table 21. Global Key Players of Drug based on CAR T-Cell, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug based on CAR T-Cell Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Drug based on CAR T-Cell Revenue Market Share by Type (2020-2025)
Table 25. Global Drug based on CAR T-Cell Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Drug based on CAR T-Cell Revenue Market Share by Type (2026-2031)
Table 27. Global Drug based on CAR T-Cell Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Drug based on CAR T-Cell Revenue Market Share by Application (2020-2025)
Table 29. Global Drug based on CAR T-Cell Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Drug based on CAR T-Cell Revenue Market Share by Application (2026-2031)
Table 31. North America Drug based on CAR T-Cell Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Drug based on CAR T-Cell Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Drug based on CAR T-Cell Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Drug based on CAR T-Cell Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Drug based on CAR T-Cell Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Drug based on CAR T-Cell Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Drug based on CAR T-Cell Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drug based on CAR T-Cell Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Drug based on CAR T-Cell Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Drug based on CAR T-Cell Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Drug based on CAR T-Cell Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2026-2031) & (US$ Million)
Table 46. Novartis Company Details
Table 47. Novartis Business Overview
Table 48. Novartis Drug based on CAR T-Cell Product
Table 49. Novartis Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Gilead Sciences Company Details
Table 52. Gilead Sciences Business Overview
Table 53. Gilead Sciences Drug based on CAR T-Cell Product
Table 54. Gilead Sciences Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 55. Gilead Sciences Recent Development
Table 56. Bristol-Myers Squibb Company Details
Table 57. Bristol-Myers Squibb Business Overview
Table 58. Bristol-Myers Squibb Drug based on CAR T-Cell Product
Table 59. Bristol-Myers Squibb Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 60. Bristol-Myers Squibb Recent Development
Table 61. J & J Company Details
Table 62. J & J Business Overview
Table 63. J & J Drug based on CAR T-Cell Product
Table 64. J & J Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 65. J & J Recent Development
Table 66. JW Therapeutics Company Details
Table 67. JW Therapeutics Business Overview
Table 68. JW Therapeutics Drug based on CAR T-Cell Product
Table 69. JW Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 70. JW Therapeutics Recent Development
Table 71. FOSUNKite Company Details
Table 72. FOSUNKite Business Overview
Table 73. FOSUNKite Drug based on CAR T-Cell Product
Table 74. FOSUNKite Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 75. FOSUNKite Recent Development
Table 76. CARsgen Therapeutics (Pipeline) Company Details
Table 77. CARsgen Therapeutics (Pipeline) Business Overview
Table 78. CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product
Table 79. CARsgen Therapeutics (Pipeline) Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 80. CARsgen Therapeutics (Pipeline) Recent Development
Table 81. CARsgen Therapeutics Company Details
Table 82. CARsgen Therapeutics Business Overview
Table 83. CARsgen Therapeutics Drug based on CAR T-Cell Product
Table 84. CARsgen Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 85. CARsgen Therapeutics Recent Development
Table 86. Autolus Therapeutics Company Details
Table 87. Autolus Therapeutics Business Overview
Table 88. Autolus Therapeutics Drug based on CAR T-Cell Product
Table 89. Autolus Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 90. Autolus Therapeutics Recent Development
Table 91. Sorrento Therapeutics Company Details
Table 92. Sorrento Therapeutics Business Overview
Table 93. Sorrento Therapeutics Drug based on CAR T-Cell Product
Table 94. Sorrento Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 95. Sorrento Therapeutics Recent Development
Table 96. Mustang Bio Company Details
Table 97. Mustang Bio Business Overview
Table 98. Mustang Bio Drug based on CAR T-Cell Product
Table 99. Mustang Bio Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 100. Mustang Bio Recent Development
Table 101. Bluebird Bio Company Details
Table 102. Bluebird Bio Business Overview
Table 103. Bluebird Bio Drug based on CAR T-Cell Product
Table 104. Bluebird Bio Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 105. Bluebird Bio Recent Development
Table 106. Cellectis Company Details
Table 107. Cellectis Business Overview
Table 108. Cellectis Drug based on CAR T-Cell Product
Table 109. Cellectis Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 110. Cellectis Recent Development
Table 111. Allogene Therapeutics Company Details
Table 112. Allogene Therapeutics Business Overview
Table 113. Allogene Therapeutics Drug based on CAR T-Cell Product
Table 114. Allogene Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 115. Allogene Therapeutics Recent Development
Table 116. Celyad Company Details
Table 117. Celyad Business Overview
Table 118. Celyad Drug based on CAR T-Cell Product
Table 119. Celyad Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 120. Celyad Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Drug based on CAR T-Cell Picture
Figure 2. Global Drug based on CAR T-Cell Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug based on CAR T-Cell Market Share by Type: 2024 VS 2031
Figure 4. CD19-targeted Features
Figure 5. BCMA-targeted Features
Figure 6. Global Drug based on CAR T-Cell Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Drug based on CAR T-Cell Market Share by Application: 2024 VS 2031
Figure 8. Lymphoma Case Studies
Figure 9. Multiple Myeloma Case Studies
Figure 10. Drug based on CAR T-Cell Report Years Considered
Figure 11. Global Drug based on CAR T-Cell Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Drug based on CAR T-Cell Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Drug based on CAR T-Cell Market Share by Region: 2024 VS 2031
Figure 14. Global Drug based on CAR T-Cell Market Share by Players in 2024
Figure 15. Global Top Drug based on CAR T-Cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug based on CAR T-Cell as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Drug based on CAR T-Cell Revenue in 2024
Figure 17. North America Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Drug based on CAR T-Cell Market Share by Country (2020-2031)
Figure 19. United States Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Drug based on CAR T-Cell Market Share by Country (2020-2031)
Figure 23. Germany Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Drug based on CAR T-Cell Market Share by Region (2020-2031)
Figure 31. China Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Drug based on CAR T-Cell Market Share by Country (2020-2031)
Figure 39. Mexico Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Drug based on CAR T-Cell Market Share by Country (2020-2031)
Figure 43. Turkey Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Novartis Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 47. Gilead Sciences Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 49. J & J Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 50. JW Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 51. FOSUNKite Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 52. CARsgen Therapeutics (Pipeline) Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 53. CARsgen Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 54. Autolus Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 55. Sorrento Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 56. Mustang Bio Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 57. Bluebird Bio Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 58. Cellectis Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 59. Allogene Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 60. Celyad Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
